Old migraine drug gets new shot at healing spinal injuries
NCT ID NCT06677229
Summary
This early-stage trial is testing whether a migraine medication called Eletriptan can help people recover function after a recent spinal cord injury. Researchers will give the drug to 28 adults with thoracic spinal injuries within 24 hours of their injury to see if it's safe and if it improves movement. The study repurposes a drug with 20 years of safety history to potentially help the nervous system heal.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY (SCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario La Paz
RECRUITINGMadrid, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Universitario Reina Sofia
RECRUITINGCórdoba, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.